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Abstract
We propose and analyse an optimal control problem where the control system is a math-
ematical model for tuberculosis that considers reinfection. The control functions represent
the fraction of early latent and persistent latent individuals that are treated. Our aim is
to study how these control measures should be implemented, for a certain time period, in
order to reduce the number of active infected individuals, while minimizing the interventions
implementation costs. The optimal intervention is compared along different epidemiological
scenarios, by varying the transmission coefficient. The impact of variation of the risk of rein-
fection, as a result of acquired immunity to a previous infection for treated individuals on the
optimal controls and associated solutions, is analysed. A cost-effectiveness analysis is done,
to compare the application of each one of the control measures, separately or in combination.
Keywords: tuberculosis; optimal control; post-exposure interventions; efficacy function; cost
effort.
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1 Introduction
Tuberculosis (TB) detection and treatment saved 22 million of lives, between 1995 and 2012,
following the 2013 report of the World Health Organization (WHO) [28]. However, in 2012, there
were 8.6 million of new TB cases and 1.3 million of TB deaths [28]. TB prevention, diagnosis and
treatment, requires adequate funding, sustained over many years, which represents a worldwide
scale challenge.
Mathematical dynamic models are an important tool in analyzing the spread and control of
infectious diseases. Many TB mathematical models have been developed — see, e.g., [1,3,6,7,9,23]
and the references cited therein. The main differences of the models proposed in [2, 5–7, 9, 10, 16,
18,23,24] are the way they represent reinfection, since there is no consensus on wether a previous
infection gives or not protection. The way recently infected individuals progress to active disease
is not the same in all models: they can be “fast progressors” or “slow progressors”. In some
models, it is assumed that only 5 to 10% of the infected individuals are fast progressors. The
remaining models consider that individuals are able to contain the infection asymptomatic and
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non infectiously (latent individuals), having a much lower probability of developing active disease
by endogenous reactivation. More recent models also assume exogenous reinfection of latent and
treated individuals, based on the fact that infection and/or disease do not confer full protection
[22]. This assumption has an important impact on the efficacy of interventions [6, 9, 18–21, 23].
In this paper, we consider a TB mathematical model from [10], where exogenous reinfection is
considered.
Without treatment, TB mortality rates are hight [28]. Different interventions are available
for TB prevention and treatment: vaccination to prevent infection; treatment to cure active TB;
treatment of latent TB to prevent endogenous reactivation. In this work, we study the imple-
mentation of two post-exposure interventions that are not widely used: treatment of early latent
individuals with anti-TB drugs (e.g., treatment of recent contacts of index cases) and prophylactic
treatment/vaccination of the persistent latent individuals. We propose an optimal control problem
that consists in analyzing how these two control measures should be implemented, for a certain
time period, in order to reduce the number of active infected individuals, while controlling the
interventions implementation costs.
Optimal control is a branch of mathematics developed to find optimal ways to control a dynamic
system [4,8,15]. Other authors applied optimal control theory to TB models (see, e.g., [11,13,20]).
This approach allows the study of the most cost-effective intervention design by generating an
implementation design that minimizes an objective function. The intensity of interventions can
be relaxed along time, which is not the case considered in most models, for which interventions
are modeled by constant rates [10].
The paper is organized as follows. In Section 2 we present the mathematical model for TB that
will be study in this paper. Two control functions u1 and u2 are then added to the original model
from [10]. Section 3 is dedicated to the formulation of the optimal control problem. We prove the
existence of an unique solution and derive the expression for the optimal controls according to the
Pontryagin maximum principle [15]. Section 4 has four subsections dedicated to a numerical and
cost-effectiveness analysis of the optimal control problem. We start by illustrating the problem
solutions for a particular case (Section 4.1). We then introduce some summary measures in
Section 4.2 to describe how the results change when varying transmission intensity (Section 4.3)
and protection against reinfection (Section 4.4). In Section 4.5, we analyze the cost-effectiveness of
three intervention strategies: applying u1 or u2 separately and applying the two control measures
simultaneously. We end with Section 5 of discussion.
2 Mathematical model
Following the model proposed in [10], population is divided into five categories: susceptible (S);
early latent (L1), i.e., individuals recently infected (less than two years) but not infectious; infected
(I), i.e., individuals who have active TB and are infectious; persistent latent (L2), i.e., individuals
who were infected and remain latent; and recovered (R), i.e., individuals who were previously
infected and treated.
We assume that at birth all individuals are equally susceptible and differentiate as they expe-
rience infection and respective therapy. The rate of birth and death, µ, are equal (corresponding
to a mean life time of 70 years [10]) and no disease-related deaths are considered, keeping the total
population, N , constant with N = S(t) + L1(t) + I(t) + L2(t) +R(t).
Parameter δ denotes the rate at which individuals leave L1 compartment; φ is the proportion
of infected individuals progressing directly to the active disease compartment I; ω and ωR are the
rates of endogenous reactivation for persistent latent infections (untreated latent infections) and
for treated individuals (for those who have undergone a therapeutic intervention), respectively.
Parameters σ and σR are factors that reduce the risk of infection, as a result of acquired immunity
to a previous infection, for persistent latent individuals and for treated patients, respectively.
These factors affect the rate of exogenous reinfection. As in [10], in our simulations we consider
three different cases for the protection against reinfection conferred by treatment: same protection
as natural infection (σR = σ); lower protection than conferred by infection (σR = 2σ); and higher
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protection than conferred by infection (σR = σ/2), see Section 4.4. Parameter τ0 is the rate of
recovery under standard treatment of active TB, assuming an average duration of infectiousness
of six months. The values of the rates δ, φ, ω, ωR, σ and τ0 are taken from [10] and the references
cited therein (see Table 1 for the values of the parameters).
Additional to standard treatment of infectious individuals, we consider two post-exposure in-
terventions targeting different sub-populations: early detection and treatment of recently infected
individuals (L1) and chemotherapy or post-exposure vaccine of persistent latent individuals (L2).
These interventions are applied at rates τ1 and τ2. We consider, without loss of generality, that
the rate of recovery of early latent individuals under post-exposure interventions is equal to the
rate of recovery under treatment of active TB, τ1 = 2 yr
−1, and greater than the rate of recovery
of persistent latent individuals under post-exposure interventions, τ2 = 1 yr
−1 [10]. Since we are
interested in studying these interventions along time, we add to the original model two control
functions, u1(·) and u2(·), which represent the intensity at which these post-exposure interventions
are applied at each time step.
The dynamical control system that we propose is given by

S˙(t) = µN − β
N
I(t)S(t)− µS(t)
L˙1(t) =
β
N
I(t) (S(t) + σL2(t) + σRR(t))− (δ + τ1u1(t) + µ)L1(t)
I˙(t) = φδL1(t) + ωL2(t) + ωRR(t)− (τ0 + µ)I(t)
L˙2(t) = (1− φ)δL1(t)− σ
β
N
I(t)L2(t)− (ω + τ2u2(t) + µ)L2(t)
R˙(t) = τ0I(t) + τ1u1(t)L1(t) + τ2u2(t)L2(t)− σR
β
N
I(t)R(t) − (ωR + µ)R(t) .
(1)
Remark 2.1. The assumption that the total population N is constant, allows to reduce the control
system (1) from five to four state variables. We decided to maintain the TB model in form (1),
using relation S(t) + L1(t) + I(t) + L2(t) +R(t) = N as a test to confirm the numerical results.
Symbol Description Value
β Transmission coefficient variable
µ Death and birth rate 1/70 yr−1
δ Rate at which individuals leave L1 12 yr
−1
φ Proportion of individuals going to I 0.05
ω Rate of endogenous reactivation for persistent latent infections 0.0002 yr−1
ωR Rate of endogenous reactivation for treated individuals 0.00002 yr
−1
σ Factor reducing the risk of infection as a result of acquired
immunity to a previous infection for L2 0.25
σR Rate of exogenous reinfection of treated patients σ; 2σ;σ/2
τ0 Rate of recovery under treatment of active TB 2 yr
−1
τ1 Rate of recovery under treatment of latent individuals L1 2 yr
−1
τ2 Rate of recovery under treatment of latent individuals L2 1 yr
−1
N Total population 30000
tf Total simulation duration 5 yr
W0 Weight constant on active infectious individuals I(t) 50
W1 Weight constant on control u1(t) 50
W2 Weight constant on control u2(t) 50
Table 1: Parameter values for the control system (1).
It is assumed that the rate of infection of susceptible individuals is proportional to the number of
infectious individuals and the constant of proportionality is β, which is the transmission coefficient.
The basic reproduction number R0, for system (1) in the absence of post-exposure interventions,
i.e., in the case u1 = u2 = 0, is proportional to the transmission coefficient β (see [10]) and is
given by
R0 = β
δ(ω + φµ)(ωR + µ)
µ(ωR + τ0 + µ)(δ + µ)(ω + µ)
.
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The endemic threshold (ET ) at R0 = 1 indicates the minimal transmission potential that sustains
endemic disease, i.e., when R0 < 1 the disease will die out and for R0 > 1 the disease may become
endemic. Since our model considers reinfection and post-exposure interventions, the reinfection
threshold RT becomes important. It corresponds to critical transmissibility values above which
there is a steep nonlinear increase in disease prevalence, corresponding to the increase contribute
of reinfection cases to the disease load. The RT for the system (1), in the absence of post-exposure
interventions, has been computed in [10].
3 Optimal control problem
TB control is still a common problem around the world. In order to have the desire impact,
TB control measures must be timely applied. However, economical, social and environmental
constraints are imposed to TB control measures. The ideal situation would be a minimization
of active infected individuals with the lowest cost possible. Optimal control theory is a powerful
mathematical tool that can be used to make decisions in this situation [12].
We consider the state system (1) of ordinary differential equations in R5 with the set of ad-
missible control functions given by
Ω =
{
(u1(·), u2(·)) ∈ (L
∞(0, tf ))
2 | 0 ≤ u1(t), u2(t) ≤ 1, ∀ t ∈ [0, tf ]
}
.
Our aim is to minimize the number of active infected individuals I as well as the costs required to
control the disease by treating early and persistent latent individuals, L1 and L2. The objective
functional is given by
J (u1(·), u2(·)) =
∫ tf
0
[
W0I(t) +
W1
2
u21(t) +
W2
2
u22(t)
]
dt , (2)
where the constants Wi, i = 1, 2, are a measure of the relative cost of the interventions associated
to the controls u1 and u2, respectively, and the constant W0 is the weight constant for classe I.
We consider the optimal control problem of determining (S∗(·), L∗1(·), I
∗(·), L∗2(·), R
∗(·)), asso-
ciated to an admissible control pair (u∗1(·), u
∗
2(·)) ∈ Ω on the time interval [0, tf ], satisfying (1),
given initial conditions S(0), L1(0), I(0), L2(0) and R(0) and minimizing the cost function (2),
i.e.,
J (u∗1(·), u
∗
2(·)) = min
Ω
J (u1(·), u2(·)) . (3)
In A we prove the following existence and uniqueness result.
Theorem 3.1. Problem (1)–(3) with given initial conditions S(0), L1(0), I(0), L2(0) and R(0)
and fixed final time tf , admits an unique optimal solution (S
∗(·), L∗1(·), I
∗(·), L∗2(·), R
∗(·)) associ-
ated to an optimal control pair (u∗1(·), u
∗
2(·)) on [0, tf ].
The optimal control pair predicted by Theorem 3.1 represents the optimal intervention strategy,
given the cost constraints, and can be found by application of the celebrated Pontryagin maximum
principle [15] (Lemma in A) and appropriate numerical methods [17].
4 Numerical results and cost-effectiveness analysis
Different approaches were used to obtain and confirm the numerical results. One approach con-
sisted in using IPOPT [26] and the algebraic modeling language AMPL [25]. A second approach
was to use the PROPT Matlab Optimal Control Software [27]. The results coincide with the ones
obtained by an iterative method that consists in solving the system of ten ODEs given by (1) and
(11) (Lemma in A). For that, first we solve system (1) with a guess for the controls over the time
interval [0, T ] using a forward fourth-order Runge–Kutta scheme and the transversality conditions
λi(T ) = 0, i = 1, . . . , 5. Then, system (11) is solved by a backward fourth-order Runge–Kutta
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scheme using the current iteration solution of (1). The controls are updated by using a convex
combination of the previous controls and the values from (12). The iteration is stopped when the
values of the unknowns at the previous iteration are very close to the ones at the present iteration.
In the following sections all parameters are fixed according to Table 1, with exception to
the transmission parameter β and the reinfection parameter for treated individuals σR, which
are varied to illustrate different scenarios. The initial conditions are obtained as the nontrivial
equilibria values for the system (1) with no controls (u1 = 0 = u2), corresponding to the population
state before the introduction of post-exposure interventions.
4.1 An example of optimal control for a period of five years
For illustration, we fix all parameters according to Table 1. We start by considering β = 100 and
the simplest case where latent (L1 and L2) and recovered (R) individuals have the same protection
against reinfection, i.e., σR = σ. Both these assumptions will be relaxed latter on, in Sections 4.3
and 4.4. Initial conditions are given in Table 2. The solution for the optimal control problem
S(0) L1(0) I(0) L2(0) R(0)
4 554 72 24 23 950 1 400
Table 2: Initial conditions for system (1) with parameters according to Table 1 and for β = 100 and
σR = σ. The values are obtained as the endemic equilibria values for (1) before the introduction
of post-exposure interventions (i.e., u1 = 0 = u2).
is illustrated in Figure 1 (a) and (b). During the five years, for which the interventions lasts,
the number of infectious individuals decreases and both interventions can be relaxed along time.
Treatment intensity of the persistent latent individuals u2 must be maximum during the initial
2 years and then can be progressively reduced. Treatment of early latent individuals u1 should
stay longer at its maximum intensity, for approximately 4 years. Figure 1 (c) shows the efficacy
function defined by
E(t) =
I(0)− I∗(t)
I(0)
= 1−
I∗(t)
I(0)
, (4)
where I∗(t) is the optimal solution associated to the optimal controls and I(0) is the corresponding
initial condition. This function measures the proportional decrease in the number of infectious
individuals imposed by the intervention with controls (u1, u2), by comparing the number of infected
individuals at time t with the initial value I(0) for which there are no controls implemented
(u1 = u2 = 0). By construction, E(t) ∈ [0, 1] for all time t and the efficacy is highest when E(t)
is one. Note that E(t) has the contrary tendency of I(t).
Naturally, the results depend on the objective function J given by (2). In particular, they
depend on the duration of the intervention tf and on the weight constants associated with the
amount of infectious individuals W0 and with the costs of controls Wi, i = 1, 2. WHO goals
are usually fixed for five years periods, so in what follows, we assume tf = 5 years. Moreover,
for higher values of tf (tf ∈ {10, . . . , 25}) we can observe that the number of infected individuals
starts to increase towards the end of the intervention (B). In practical terms, this would mean that
the intervention should be revised before its end. Results do not change qualitatively by varying
constants Wi, i = 0, 1, 2. However, the magnitude of the efficacy changes more significantly in
the cases where W0 and W1 = W2 are varied independently. Generally, efficacy decreases when
the costs W1 and W2 increase, corresponding to earlier relaxation of the intensity of treatment
(u1(t), u2(t)) in the optimal solution. More details can be found in C.
More importantly, these results will change depending on the epidemiological scenario we
consider. In the next subsections we vary the transmission coefficient β and on the protection
conferred by treatment σR.
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Figure 1: Solution for the optimal control problem (1)–(3), assuming tf = 5, β = 100 and σR = σ.
(a) Optimal control pair u1 (continuous line) and u2 (dashed line). (b) Number of infectious
individuals along time. (c) Efficacy function E(t), defined by (4).
4.2 Summary measures
We introduce some summary measures to evaluate the cost and the effectiveness of the proposed
control measures for the entire intervention period, for different epidemiological scenarios.
For each β and σR fixed, the total cases averted by the intervention during the time period tf
is given by
A(β, σR) = tfI(0;β, σR)−
∫ tf
0
I∗(t;β, σR)dt, (5)
where, for each β and σR fixed, I
∗(t;β, σR) = I
∗(t) is the optimal solution associated to the optimal
controls (u∗1, u
∗
2) and I(0;β, σR) = I(0) is the corresponding initial condition. Note that this initial
condition is obtained as the equilibrium proportion I(β, σR) of system (1) with no post-exposure
intervention (u1 = u2 = 0), which does not depend on time, so tfI(0;β, σR) =
∫ tf
0
I(β, σR)dt
represents the total infectious cases over a period of tf years.
We define effectiveness as the proportion of cases averted on the total cases possible under no
intervention:
E(β, σR) =
A(β, σR)
tfI(0;β, σR)
= 1−
∫ tf
0
I∗(t;β, σR)dt
tfI(0;β, σR)
. (6)
We choose dimensionless measures for effectiveness to be able to compare different epidemiological
scenarios.
The total cost associated to the intervention is
TC(β, σR) =
∫ tf
0
C1u
∗
1(t)L
∗
1(t) + C2u
∗
2(t)L
∗
2(t)dt, (7)
where Ci correspond to the per person unit cost of the two possible interventions: detection
and treatment of early latent individuals (C1) and chemotherapy/vaccination of persistent latent
individuals (C2). Following [14], we define the average cost-effectiveness ratio by
ACER =
TC
A
. (8)
Typically, optimal solutions correspond to maximum intensity of intervention for a certain period
followed by relaxation, as in the example in Section 4.1. So, we use the time at which the intensity
of each intervention is relaxed as another way to evaluate the effort associated with an optimal
solution:
tri = tri(β, σR) = max{t ∈ [0, tf ] : ui(t;β, σR) = 1}, i = 1, 2.
We refer to these as relaxation-times. Table 3 summarizes the particular case analyzed in the
previous section, β = 100 and σR = σ.
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β A TC ACER E tr1 tr2
100 56 23 374 417 0.4691 4.1765 2.0
Table 3: Summary of cost-effectiveness measures for β = 100 and σR = σ.
4.3 Impact of transmission intensity on optimal control interventions
First we compare model results for different epidemiological scenarios in terms of transmission
intensity, by varying parameter β. For now, we assume that protection conferred by natural
infection or by treatment is the same (σR = σ). The remaining parameters are fixed according to
Table 1.
Figure 2 represents effectiveness E and relaxation-times tri , i = 1, 2, for the optimal control
measures, when varying transmission intensity β. Effectiveness is a monotonically decreasing
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(b) tri for variable β (σR = σ).
Figure 2: (a) Effectiveness E, and (b) Relaxation-times (tr1 full line and tr2 dashed line), for
variable β and σR = σ. Parameters according to Table 1.
function on β. The reinfection threshold RT , marked by the dotted vertical line, coincides with
a change in curvature of E(β) from concave to convex (Figure 2a). For all endemic scenarios,
maximum intensity of treatment of early latent individuals is required for longer periods than
treatment of persistent latent individuals (Figure 2b). Below the RT , the relaxation-times of
both post-exposure interventions increase with β. However, above the RT , treatment of early
latent individuals is required at its maximum intensity for almost the entire five year period (tf )
and the intervention on persistent latent individuals is needed for shorter periods. For very high
transmission intensity, relaxation time for intervention on persistent latent individuals is zero
(tr2 = 0), corresponding to a singular control.
Depending on the background epidemiological scenario, we can have different optimal interven-
tion strategies. For example, for β = 100 the optimal solution corresponds to both interventions
with relaxation-times of tr1 = 4.1765 and tr2 = 2.0 years and for β = 250 the optimal solution
corresponds to treatment of early latent individuals for approximately the entire intervention pe-
riod, tr1 = 4.941 years and treat persistent individuals at intensity always below the maximum
u∗2(t) < 1, for t ∈ [0, tf ] (results not shown). These interventions are associated with very different
effectiveness, 45% (E(100) = 0.4691) and 20% (E(250) = 0.2005), respectively.
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4.4 Impact of protection against reinfection of the treated individuals
(σR 6= σ) on optimal control interventions
In this section we relax the assumption that latent (L1 and L2) and treated (R) individuals have the
same protection to reinfection. Given the lack of published studies supporting on of the hypothesis,
we explore both possibilities, as in [10]: treatment enhances protection against reinfection (σR < σ)
or protection is impaired by treatment (σR > σ). To illustrate, we will use σR = σ/2 and σR = 2σ,
respectively. Results are very different for the two scenarios. If protection against reinfection is
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Figure 3: (a) Effectiveness E, (b)–(c) Relaxation-times tr1 and tr2 , for variable β. Full and
dashed lines correspond to cases σR = σ/2 and σR = 2σ, respectively. Parameters according to
Table 1.
enhanced by treatment (σR = σ/2), then the optimal solution corresponds to treat both early and
persistent latent individuals at maximum intensity for a certain period, ranging from 1.5 to 5 years,
followed by relaxation of the intervention intensity (full lines in Figure 3b and 3c). The relaxation-
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Figure 4: (a) Control u1, (b) Control u2 for β = 100. Full and dashed lines correspond to cases
σR = σ/2 and σR = 2σ, respectively. Parameters according to Table 1.
times increase with β. However, if treatment impairs protection, then the optimal intervention
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would be to treat early latent at maximum intensity for longer periods and to treat persistent
latent individuals almost always below the maximum intensity (dashed lines in Figure 3b and 3c).
Actually, in this case the optimal solution can impose not to treat persistent latent individuals
(u∗2 = 0 for t ∈ [0, tf ]) as illustrated in Figure 4 for the case β = 100. In both cases, effectiveness
peaks close to the reinfection threshold RT .
4.5 Optimal controls strategy and cost-effectiveness analysis
In this section we analyse the cost-effectiveness of alternative combinations of the two possible
control measures: strategy a – implementing both controls u1 and u2, corresponding to intervene
on both early and persistent latent individuals, as in previous sections; strategy b – implementing
only control measure u1; and strategy c – only control measure u2, separately.
For each value of β, we compute the optimal solution for the three strategies and calculate the
associated effectiveness E. In Figure 5a we can see that, below the reinfection threshold RT , the
strategy using interventions on both population groups has higher effectiveness. However, above
the RT this advantage is marginal, comparing with the intervention on early latent individuals,
only. From Figure 5b, we can have one idea of the time design of the optimal intervention for
50 100 150 200 250 300 350 400
0
0.1
0.2
0.3
0.4
0.5
 β
E
(a)
50 100 150 200 250 300 350 400
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
β
R
el
ax
at
io
n 
tim
es
,  
t r1
,
 
t r2
(b)
Figure 5: (a) Effectiveness E and (b) Relaxation-times, tr1 or tr2 , for variable β. Grey lines
correspond to intervention with both controls u1 and u2. Black full and dashed lines correspond
to interventions with only u1 or u2, respectively. Parameters according to Table 1 and σR = σ.
each case. Intervention on early latent individuals only, corresponds to a control at maximum
intensity for long periods (very high tr1). When intervening on persistent latent individuals only,
maximum intensity of control is required for shorter periods which are close to zero for very high
transmission intensity, corresponding to singular controls.
For a particular epidemiological scenario (fixed β and σR), we can use a more classical approach
to analyse the cost-effectiveness of the three alternative strategies by using the incremental cost
effectiveness ratio (ICER) in [14]. This ratio is used to compare the differences between the costs
and health outcomes of two alternative intervention strategies that compete for the same resources
and it is generally described as the additional cost per additional health outcome. First, we must
rank the strategies in order of increasing effectiveness, here measured as the total infections averted
A(β, σR), defined in (8). Given two competing strategies a and b, the ICER of the strategy with
the least effectiveness is its ACER and for the following strategies is given by
ICER(b) =
A(b)−A(a)
TC(b)− TC(a)
.
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For illustration, we focus on an epidemiological scenario of moderate transmission with β = 100.
Results are shown in Table 4. Strategy c has a unit cost of 1 485, it is more costly and less effective
than strategy b, so we exclude strategy c from the set of alternatives. We align the remaining al-
Strategy A TC ACER ICER
c 24 35 640 1 485 1 485
b 37 211 5.7 −1 721
a 56 23 374 417.4 1 207
Table 4: Incremental cost-effectiveness ratio for alternative strategies a, b and c, with β = 100.
Parameters according to Table 1, C1 = C2 = 1 and σR = σ.
ternative strategies by increasing effectiveness and recompute the ICER: ICER(b)=ACER(b)=5.7
and ICER(a)=1 207. Hence, we conclude that strategy b has the least ICER and therefore is more
cost-effective than strategy a. For this illustration we have considered the same cost for both in-
terventions (C1 = C2 = 1). Results should depend strongly on the choice of these parameters,
however this discussion is out of the scope of our present work.
5 Discussion
In this work we study the potential of widespread of two post-exposure interventions that are
not widely used: treatment of early latent individuals and prophylactic treatment/vaccination of
persistent latent individuals. We propose an optimal control problem that consists in analysing
how these two control measures should be implemented, for a certain time period, in order to reduce
the number of active infected individuals, while controlling the interventions implementation costs.
This approach differs from others [1,3,7,10] since it allows intensity of intervention to be changed
along time.
As previous suggested [9, 10], interventions impact can be sensitive to transmission intensity
and reinfection. We choose a dimensionless measure of effectiveness to compare different scenarios:
assuming different transmission intensity (β) or assuming different assumptions on protection
against reinfection conferred by treatment (σR).
Effectiveness of optimal intervention decreases with transmission. There is a change in the
intervention profile from low to high transmission. In high transmission settings, the intensity of
treatment of persistent latent individuals u∗2 for the optimal solution is reduced. Since treatment
of persistent latent individuals reduces the reactivation rate (from ω to ωR), when reinfection
is very common and it overcomes reactivation impact, the advantage of treating this population
group is less pronounced.
The susceptibility to reinfection after treatment is still an open question. In one hand, treat-
ment can reduce the risk of TB by reducing the amount of bacteria present in the lungs. On the
other hand, we can argue that latent infection boosts immunity by constant stimulation of the
immune system, so treatment could reduce protection. We vary parameter σR to explore these
two possible scenarios: σR = σ/2 when treatment enhances protection and σR = 2σ when treat-
ment impairs protection. Results show that treatment of persistent latent individuals should be
less intense or even absent for the case where treatment impairs protection. Similar results were
obtained for the case of constant treatment rates in [10]. In fact, for the correspondent case with
maximum intensity (u1 ≡ 1 and u2 ≡ 1), we can have an increase of the equilibrium proportion
of infectious individuals (t→∞).
We can conclude that reinfection has an important role in the determination of the optimal
control strategy, by diminishing the intervention intensity on persistent latent individuals: first
when transmission is very high corresponding to a very high reinfection rate and secondly when this
population group has a lower susceptibility to reinfection (σ < σR). Interestingly, the reinfection
threshold RT of the model with no controls still marks a change in the model behaviour. Even
though, we are comparing equilibrium results to transient short time interventions.
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Cost-effectiveness analysis of alternative combinations of the two interventions is conducted.
For β = 100, treatment of only early latent individuals is the more cost-effective strategy, despite
of treatment of both early latent and persistent latent individuals having a higher effectiveness.
The total cost associated with treatment of persistent latent individuals is very high, especially
because this population group can be very big in comparison to the others. It is believed that
about one third of world’s population is latent infected with TB. Here, for simplicity, we have
considered the cost parameters both equal to one. However, this depends greatly on the type of
intervention used and results can be changed. For example, if intervention on persistent latent
individuals could be done by vaccination, then the per person unit cost could be significantly
reduced. Plus, treatment of early latent individuals implies contact tracing of index cases and
prophylactic treatment, which can also be very expensive.
A Proof of Theorem 3.1
The Hamiltonian H associated to the problem in (1) is given by
H = H(S(t), L1(t), I(t), L2(t), R(t), λ(t), u1(t), u2(t))
=W0I(t) +
W1
2
u21(t) +
W2
2
u22(t)
+ λ1(t)
(
µN −
β
N
I(t)S(t)− µS(t)
)
+ λ2(t)
(
β
N
I(t) (S(t) + σL2(t) + σRR(t))− (δ + τ1u1(t) + µ)L1(t)
)
+ λ3(t) (φδL1(t) + ωL2(t) + ωRR(t)− (τ0 + µ)I(t))
+ λ4(t)
(
(1− φ)δL1(t)− σ
β
N
I(t)L2(t)− (ω + τ2u2(t) + µ)L2(t)
)
+ λ5(t)
(
τ0I(t) + τ1u1(t)L1(t) + τ2u2(t)L2(t)− σR
β
N
I(t)R(t)− (ωR + µ)R(t)
)
,
where λ(t) = (λ1(t), λ2(t), λ3(t), λ4(t), λ5(t)) is the adjoint vector. According to the Pontryagin
maximum principle [15], if (u∗1(·), u
∗
2(·)) ∈ Ω is optimal for problem (1)–(3) with the initial condi-
tions given in Table 2 and fixed final time tf , then there exists a nontrivial absolutely continuous
mapping λ : [0, tf ]→ R
5, λ(t) = (λ1(t), λ2(t), λ3(t), λ4(t), λ5(t)), such that
S˙ =
∂H
∂λ1
, L˙1 =
∂H
∂λ2
, I˙ =
∂H
∂λ3
, L˙2 =
∂H
∂λ4
, R˙ =
∂H
∂λ5
and
λ˙1 = −
∂H
∂S
, λ˙2 = −
∂H
∂L1
, λ˙3 = −
∂H
∂I
, λ˙4 = −
∂H
∂L2
, λ˙5 = −
∂H
∂R
. (9)
The minimality condition
H(S∗(t),L∗1(t), I
∗(t), L∗2(t), R
∗(t), λ∗(t), u∗1(t), u
∗
2(t))
= min
0≤u1,u2≤1
H(S∗(t), L∗1(t), I
∗(t), L∗2(t), R
∗(t), λ∗(t), u1, u2)
(10)
holds almost everywhere on [0, tf ]. Moreover, the transversality conditions
λi(tf ) = 0, i = 1, . . . , 5 ,
hold.
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Lemma. For problem (1)–(3) with fixed initial conditions S(0), L1(0), I(0), L2(0) and R(0) and
fixed final time tf , there exists adjoint functions λ
∗
1(·), λ
∗
2(·), λ
∗
3(·), λ
∗
4(·) and λ
∗
5(·) such that

λ˙∗
1
(t) = λ∗1(t)
(
β
N
I∗(t) + µ
)
− λ∗2(t)
β
N
I∗(t)
λ˙∗
2
(t) = λ∗2(t) (δ + τ1 + µ)− λ
∗
3(t)φδ − λ
∗
4(t)(1 − φ)δ − λ
∗
5(t)τ1u
∗
1(t)
λ˙∗
3
(t) = −W0 + λ
∗
1(t)
β
N
S∗(t)− λ∗2(t)
β
N
(S∗(t) + σL∗2(t) + σRR
∗(t))
+λ∗3(t) (τ0 + µ) + λ
∗
4(t)σ
β
N
L∗2(t)− λ
∗
5(t)
(
τ0 − σR
β
N
R∗(t)
)
λ˙∗
4
(t) = −λ∗2(t)
β
N
I∗(t)σ − λ∗3(t)ω + λ
∗
4(t)
(
σ β
N
I∗(t) + ω + τ2u
∗
2(t) + µ
)
−λ∗5(t) (τ2u
∗
2(t))
λ˙∗
5
(t) = −λ∗2(t)σR
β
N
I∗(t)− λ∗3(t)ωR + λ
∗
5(t)
(
σR
β
N
I∗(t) + ωR + µ
)
,
(11)
with transversality conditions
λ∗i (tf ) = 0, i = 1, . . . , 5 .
Furthermore,
u∗1(t) = min
{
max
{
0,
τ1L
∗
1 (λ
∗
2 − λ
∗
5)
W1
}
, 1
}
,
u∗2(t) = min
{
max
{
0,
τ2L
∗
2 (λ
∗
4 − λ
∗
5)
W2
}
, 1
}
.
(12)
Proof. System (11) is derived from the Pontryagin maximum principle (see (9), [15]) and the
optimal controls (12) come from the minimality condition (10). For small final time tf , the optimal
control pair given by (12) is unique due to the boundedness of the state and adjoint functions and
the Lipschitz property of systems (1) and (11) (see [11] and references cited therein).
Proof of Theorem 3.1. Existence of an optimal solution (S∗, L∗1, I
∗, L∗2, R
∗) associated to an opti-
mal control pair (u∗1, u
∗
2) comes from the convexity of the integrand of the cost function J with
respect to the controls (u1, u2) and the Lipschitz property of the state system with respect to
state variables (S,L1, I, L2, R) (see, e.g., [4, 8]). For small final time tf , the optimal control pair
is given by (12) that is unique by the Lemma above. Because the state system (1) is autonomous,
uniqueness is valid for any time tf and not only for small time tf .
B Sensitivity analysis to the duration of intervention tf
We fix β = 100 and σR = σ and the remaining parameters according to Table 1 and vary tf . Results
for the proportion of infectious individuals are shown in the Figure 6. The general behaviour do
not change significantly with tf . The proportion of infected individuals slightly increases towards
the end of the intervention for tf > 7. This tendency is more pronounced for higher tf .
C Sensitivity analysis to the weight constants on the objec-
tive functional J
Figure 7 shows the results for different combination of the weight constants on the objective
functional J . We fix β = 100 and σR = σ and the remaining parameters according to Table 1 and
vary W0, W1 and W2. Efficacy decreases when the costs W1 and W2 increase, corresponding to
an earlier relaxation of the intensity of treatment (u1(t), u2(t)) in the optimal solution due to cost
restrictions. The change in efficacy is more pronounced for the cases where the weight associated
with infectious individuals W0 change in comparison to the weights associated with the controls
W1 = W2 (Figures 7a and 7b). Results are less sensitive to the variation between the weight
controls W1 and W2 (Figures 7c and 7d).
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Figure 6: Proportion of infectious individuals for the optimal solution I(t) with tf ∈
{5, 7, 10, 12, 15, 17, 20, 22, 25}. Parameters according to Table 1, β = 100 and σR = σ.
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